ERHSX
Price
$15.08
Change
-$0.02 (-0.13%)
Updated
Feb 21 closing price
Net Assets
977.5M
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

ERHSX vs JNGLX

Header iconERHSX vs JNGLX Comparison
Open Charts ERHSX vs JNGLXBanner chart's image
Eaton Vance Worldwide Health Sci R
Price$15.08
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets977.5M
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
ERHSX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ERHSX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERHSX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. ERHSX (977M). JNGLX pays higher dividends than ERHSX: JNGLX (0.12) vs ERHSX (0.00). ERHSX was incepted earlier than JNGLX: ERHSX (21 years) vs JNGLX (26 years). JNGLX is a more actively managed with annual turnover of: 34.00 vs. ERHSX (21.00). ERHSX has a lower initial minimum investment than JNGLX: ERHSX (1000) vs JNGLX (2500). ERHSX annual gain was more profitable for investors over the last year : -1.24 vs. JNGLX (-3.67). JNGLX return over 5 years is better than : 17.54 vs. ERHSX (11.13).
ERHSXJNGLXERHSX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years26 years-
Gain YTD6.5725.421121%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets977M5B20%
Annual Yield % from dividends0.000.12-
Returns for 1 year-1.24-3.6734%
Returns for 3 years6.2715.9739%
Returns for 5 years11.1317.5463%
Returns for 10 years9.7129.2533%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P